Achievwin
★★  

US,
2021-07-06 16:37
(1461 d 06:01 ago)

Posting: # 22459
Views: 3,694
 

 BE for a drug dosed on body weight [Study Per­for­mance]

Post reply
Has anyone have experience in designing bioequivalence trial for a (oncology or other) drug which dosing varies with body weight (varying doses)? How do you present PK across subjects receiving varying doses (dose normalize to a bench mark dose? or since BE is based on ratio it has no impact?)

Thanks for any feed back:-|
 
dshah
★★  

India,
2021-07-17 13:46
(1450 d 08:52 ago)

@ Achievwin
Posting: # 22475
Views: 2,779
 

 BE for a drug dosed on body weight

Post reply
Dear Achievwin!
If the study is crossover, then the dose administered would generally be same for that subject and thus we could assume that it would not have any impact.
Regards,
Dshah
 
UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,677 registered users;
32 visitors (0 registered, 32 guests [including 8 identified bots]).
Forum time: 22:39 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5